Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 2 | 4 | 2 | — | 9 |
Hiv | D006678 | — | O98.7 | — | 1 | — | 2 | — | 3 |
Infections | D007239 | EFO_0000544 | — | — | — | 1 | 1 | — | 2 |
Hepatitis b | D006509 | — | — | — | — | — | 2 | — | 2 |
Coinfection | D060085 | — | — | — | — | — | 1 | — | 1 |
Hepatitis | D006505 | — | K75.9 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lipodystrophy | D008060 | — | E88.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Aids-related complex | D000386 | EFO_0007137 | B20 | 1 | — | — | — | — | 1 |
Drug common name | Doxribtimine |
INN | doxribtimine |
Description | 1-(2-Deoxypentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione is a pyrimidine 2'-deoxyribonucleoside. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O |
PDB | — |
CAS-ID | 50-89-5 |
RxCUI | — |
ChEMBL ID | CHEMBL52609 |
ChEBI ID | 17748 |
PubChem CID | 1134 |
DrugBank | DB04485 |
UNII ID | VC2W18DGKR (ChemIDplus, GSRS) |